Home » Stocks » Itamar Medical

Itamar Medical Ltd. (ITMR)

Stock Price: $21.20 USD 1.28 (6.43%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 298.99M
Revenue (ttm) 33.58M
Net Income (ttm) -5.27M
Shares Out 14.10M
EPS (ttm) -0.72
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $21.20
Previous Close $19.92
Change ($) 1.28
Change (%) 6.43%
Day's Open 20.90
Day's Range 20.39 - 21.34
Day's Volume 32,659
52-Week Range 7.66 - 23.09

More Stats

Market Cap 298.99M
Enterprise Value 291.48M
Earnings Date (est) Aug 12, 2020
Ex-Dividend Date n/a
Shares Outstanding 14.10M
Float 9.37M
EPS (basic) -0.02
EPS (diluted) -0.72
FCF / Share -0.02
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 257,555
Short Ratio 19.75
Short % of Float n/a
Beta 0.51
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 8.90
PB Ratio 5.98
Revenue 33.58M
Operating Income -4.89M
Net Income -5.27M
Free Cash Flow -4.78M
Net Cash 7.52M
Net Cash / Share 0.53
Gross Margin 72.29%
Operating Margin -14.57%
Profit Margin -16.90%
FCF Margin -14.23%
ROA -6.87%
ROE -17.11%
ROIC -42.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 6
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$24.00*
(13.21% upside)
Low
21.0
Current: 21.20
High
30.0
Target: 24.00
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue31.2624.1920.7018.4416.81
Revenue Growth29.22%16.85%12.26%9.72%-
Gross Profit24.2718.4615.7013.4612.41
Operating Income-4.89-3.12-5.85-10.01-5.46
Net Income-5.27-1.73-5.30-14.40-2.25
Shares Outstanding288288288288288
Earnings Per Share-0.02-0.01-0.02-0.05-0.02
Operating Cash Flow-4.23-3.88-6.18-10.63-8.61
Capital Expenditures-0.55-0.31-0.30-0.46-0.56
Free Cash Flow-4.78-4.19-6.48-11.09-9.17
Cash & Equivalents15.126.4710.8226.140.00
Total Debt7.605.4413.5724.59-
Net Cash / Debt7.521.03-2.761.550.00
Assets33.2118.3921.2835.55-
Liabilities16.5411.7019.9030.31-
Book Value16.666.691.385.24-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Itamar Medical Ltd.
Country Israel
Employees 184
CEO Gilad Glick

Stock Information

Ticker Symbol ITMR
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: ITMR

Description

Itamar Medical Ltd. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the cardiology market. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enables home sleep tests for various sleeping disorders, including obstructive sleep apnea; and Endo PAT device that diagnoses endothelial dysfunction. The company operates in the United States, Canada, Europe, Israel, Japan, the Asia Pacific, and other countries. Itamar Medical Ltd. has a collaboration agreement with SoClean Inc. to offer WatchPAT ONE home sleep apnea test and digital health services through direct-to-consumer channels. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was founded in 1997 and is headquartered in Caesarea, Israel.